Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Acadia Healthcare Company Inc (ACHC) vs TJX Companies Inc (TJX) Price & Performance

Acadia Healthcare Company IncTrade
TJX Companies IncTrade

Price performance (Past 24H)

Key statistics

Acadia Healthcare Company Inc vs TJX Companies Inc — how do they compare? Acadia Healthcare Company Inc trades at $31.88 (market cap $2.90B), while TJX Companies Inc trades at $152.58 (market cap $172.05B). The key difference: TJX Companies Inc is far larger — about 59.3× Acadia Healthcare Company Inc's market cap, and TJX Companies Inc pays a 1.23% dividend while Acadia Healthcare Company Inc pays none. Which is the better fit depends on your goals.

ACHCTJX
Market Cap
$2.90B$172.05B
Sector
HealthConsumer Cyclical
52-Week High
$35.61$168.41
52-Week Low
$11.68$132.62
Enterprise Value
$5.29B$180.65B
Dividend Yield
1.23%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Acadia Healthcare Company Inc

ACHC trades at $31.85, up 0.22% today, with a neutral technical signal and bullish moving averages. The company reported Q2 2026 EPS of $0.38, beating estimates, but maintains negative net income margins near -33%. Revenue is stable at $3.3B, while analyst consensus is a Buy with a $36 price target. Recent news highlights ongoing litigation and operational progress.

Outlook is mixed: strong analyst support and earnings beats suggest upside, but profitability challenges and legal investigations pose significant risks. The stock's valuation appears reasonable with a P/E of 19.82, yet negative ROE and net income require careful monitoring for turnaround execution.

TJX Companies Inc

TJX trades at $154.17, down 2.92% over the past day, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $1.19 exceeding the $1.02 estimate. Revenue grew to $56.36 billion in 2025, and net income margin improved to 8.63%. Analysts maintain a bullish consensus with an average price target of $181.80, citing momentum and value prospects.

The outlook for TJX remains positive driven by consistent earnings outperformance and robust profitability metrics like a 61.25% ROE. Key risks include competitive pressures in discount retail and sensitivity to consumer spending trends. The stock offers upside to analyst targets but faces near-term technical headwinds.

Returns comparison

Trailing returns across standard periods

About Acadia Healthcare Company Inc

Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.

Read more on ACHC

About TJX Companies Inc

TJX is a leading off-price retailer of apparel, home fashions, and other merchandise. It sells a variety of branded goods, opportunistically buying inventory from a network of over 21,000 vendors worldwide. TJX targets undercutting conventional retailers' regular prices by 20%-60%, capitalizing on a flexible merchandising network, relatively low-frills stores, and a treasure-hunt shopping experience to drive margins and inventory turnover. TJX derived 79% of fiscal 2022 revenue from the United States, with 11% from Europe (mostly the United Kingdom and Germany), 9% from Canada, and the remainder from Australia. The company operated 4,689 stores at the end of fiscal 2022 under the T.J. Maxx, T.K. Maxx, Marshalls, HomeGoods, Winners, Homesense, Winners, and Sierra banners.

Read more on TJX